Intellia Therapeutics Inc
NASDAQ:NTLA
Income Statement
Earnings Waterfall
Intellia Therapeutics Inc
Revenue
|
90.8m
USD
|
Operating Expenses
|
-983.5m
USD
|
Operating Income
|
-892.7m
USD
|
Other Expenses
|
58.2m
USD
|
Net Income
|
-834.5m
USD
|
Income Statement
Intellia Therapeutics Inc
Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
3
N/A
|
4
+63%
|
6
+39%
|
7
+8%
|
9
+43%
|
13
+34%
|
16
+31%
|
21
+27%
|
23
+8%
|
25
+11%
|
26
+4%
|
27
+5%
|
29
+6%
|
29
+0%
|
30
+4%
|
33
+10%
|
37
+10%
|
40
+9%
|
43
+8%
|
46
+6%
|
51
+11%
|
62
+23%
|
58
-7%
|
52
-11%
|
42
-19%
|
27
-36%
|
33
+23%
|
38
+15%
|
45
+20%
|
51
+13%
|
52
+1%
|
53
+3%
|
53
-1%
|
52
-2%
|
36
-30%
|
91
+150%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(11)
|
(15)
|
(19)
|
(25)
|
(32)
|
(39)
|
(49)
|
(59)
|
(70)
|
(81)
|
(96)
|
(106)
|
(116)
|
(124)
|
(121)
|
(126)
|
(133)
|
(137)
|
(149)
|
(161)
|
(172)
|
(186)
|
(195)
|
(201)
|
(228)
|
(257)
|
(301)
|
(404)
|
(440)
|
(480)
|
(510)
|
(479)
|
(513)
|
(537)
|
(552)
|
(984)
|
|
Selling, General & Administrative |
(6)
|
(7)
|
(8)
|
(10)
|
(11)
|
(15)
|
(17)
|
(19)
|
(22)
|
(23)
|
(28)
|
(30)
|
(31)
|
(34)
|
(32)
|
(35)
|
(41)
|
(41)
|
(41)
|
(42)
|
(40)
|
(42)
|
(44)
|
(46)
|
(52)
|
(60)
|
(71)
|
(80)
|
(85)
|
(89)
|
(90)
|
(95)
|
(104)
|
(111)
|
(116)
|
(208)
|
|
Research & Development |
(4)
|
(8)
|
(11)
|
(15)
|
(20)
|
(25)
|
(32)
|
(40)
|
(48)
|
(58)
|
(68)
|
(77)
|
(85)
|
(90)
|
(89)
|
(90)
|
(92)
|
(97)
|
(108)
|
(119)
|
(132)
|
(144)
|
(150)
|
(155)
|
(176)
|
(197)
|
(230)
|
(324)
|
(355)
|
(391)
|
(420)
|
(384)
|
(409)
|
(426)
|
(435)
|
(776)
|
|
Operating Income |
(8)
N/A
|
(10)
-31%
|
(13)
-29%
|
(19)
-41%
|
(22)
-19%
|
(27)
-20%
|
(32)
-20%
|
(38)
-19%
|
(47)
-24%
|
(56)
-17%
|
(70)
-25%
|
(79)
-14%
|
(87)
-10%
|
(95)
-9%
|
(91)
+4%
|
(92)
-2%
|
(96)
-4%
|
(97)
-1%
|
(106)
-9%
|
(116)
-9%
|
(121)
-5%
|
(124)
-2%
|
(137)
-10%
|
(150)
-10%
|
(186)
-24%
|
(230)
-24%
|
(268)
-17%
|
(366)
-37%
|
(395)
-8%
|
(429)
-8%
|
(458)
-7%
|
(426)
+7%
|
(460)
-8%
|
(485)
-6%
|
(515)
-6%
|
(893)
-73%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
5
|
6
|
6
|
7
|
7
|
7
|
6
|
5
|
4
|
2
|
1
|
1
|
1
|
(0)
|
(2)
|
(5)
|
(5)
|
(3)
|
9
|
20
|
29
|
34
|
58
|
|
Non-Reccuring Items |
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(8)
|
(13)
|
(13)
|
(13)
|
(6)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(14)
N/A
|
(10)
+26%
|
(13)
-29%
|
(19)
-41%
|
(22)
-18%
|
(27)
-19%
|
(32)
-19%
|
(38)
-19%
|
(46)
-23%
|
(54)
-17%
|
(68)
-25%
|
(76)
-13%
|
(83)
-9%
|
(90)
-9%
|
(85)
+5%
|
(86)
-1%
|
(89)
-4%
|
(90)
-1%
|
(100)
-10%
|
(109)
-10%
|
(116)
-6%
|
(120)
-4%
|
(134)
-12%
|
(149)
-11%
|
(185)
-25%
|
(229)
-24%
|
(268)
-17%
|
(369)
-38%
|
(400)
-9%
|
(442)
-10%
|
(474)
-7%
|
(430)
+9%
|
(453)
-5%
|
(462)
-2%
|
(481)
-4%
|
(835)
-73%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(13)
|
(10)
|
(12)
|
(18)
|
(22)
|
(26)
|
(32)
|
(38)
|
(46)
|
(54)
|
(68)
|
(76)
|
(83)
|
(90)
|
(85)
|
(86)
|
(89)
|
(90)
|
(100)
|
(109)
|
(116)
|
(120)
|
(134)
|
(149)
|
(185)
|
(229)
|
(268)
|
(369)
|
(400)
|
(442)
|
(474)
|
(430)
|
(453)
|
(462)
|
(481)
|
(835)
|
|
Net Income (Common) |
(13)
N/A
|
(10)
+29%
|
(12)
-29%
|
(18)
-45%
|
(22)
-21%
|
(26)
-20%
|
(32)
-20%
|
(38)
-19%
|
(46)
-23%
|
(54)
-17%
|
(68)
-25%
|
(76)
-13%
|
(83)
-9%
|
(90)
-9%
|
(85)
+5%
|
(86)
-1%
|
(89)
-4%
|
(90)
-1%
|
(100)
-10%
|
(109)
-10%
|
(116)
-6%
|
(120)
-4%
|
(134)
-12%
|
(149)
-11%
|
(185)
-25%
|
(229)
-24%
|
(268)
-17%
|
(369)
-38%
|
(400)
-9%
|
(442)
-10%
|
(474)
-7%
|
(430)
+9%
|
(453)
-5%
|
(462)
-2%
|
(481)
-4%
|
(835)
-73%
|
|
EPS (Diluted) |
-0.39
N/A
|
-0.28
+28%
|
-0.35
-25%
|
-0.52
-49%
|
-1.14
-119%
|
-0.76
+33%
|
-1.42
-87%
|
-1.08
+24%
|
-1.34
-24%
|
-1.53
-14%
|
-1.88
-23%
|
-1.81
+4%
|
-1.93
-7%
|
-2.09
-8%
|
-1.98
+5%
|
-1.89
+5%
|
-1.95
-3%
|
-1.86
+5%
|
-2.11
-13%
|
-2.16
-2%
|
-2.17
0%
|
-2.04
+6%
|
-2.4
-18%
|
-2.21
+8%
|
-2.71
-23%
|
-3.1
-14%
|
-3.78
-22%
|
-4.93
-30%
|
-5.28
-7%
|
-5.81
-10%
|
-6.16
-6%
|
-4.9
+20%
|
-5.14
-5%
|
-5.21
-1%
|
-5.42
-4%
|
-8.73
-61%
|